Showing results (81-90 of 120) with videos related to
Sort By:
Pageof 12
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1993
Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopaM Guttman, G Léger, A Reches, et al.Bone|June 8, 2002
Overexpression of granulocyte colony-stimulating factor induces severe osteopenia in developing mice that is partially prevented by a diet containing vitamin K2 (menatetrenone)Y Kokai, T Wada, T Oda, et al.Leukemia Research|January 1, 1991
Decreased DNA polymerase sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristineM Higashigawa, M Ido, Y Nagao, et al.Journal of Neurochemistry|October 1, 1993
Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesisA Gjedde, G C Léger, P Cumming, et al.Neurology|April 22, 2009
Age-associated leukoaraiosis and cortical cholinergic deafferentationN I Bohnen, M L T M Müller, H Kuwabara, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Dopa decarboxylase activity of the living human brainA Gjedde, J Reith, S Dyve, et al.Neuropsychology|January 5, 2002
Neural activation during frequency-memory performanceM W Haut, R G Arias, M T Moran, et al.Biochemical Pharmacology|September 28, 1995
Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the ratP Cumming, A Ase, M Diksic, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Regional striatal DOPA transport and decarboxylase activity in Parkinson's diseaseH Kuwabara, P Cumming, Y Yasuhara, et al.Leukemia Research|January 1, 1991
Membrane transport of 1-beta-D-arabinofuranosylcytosine and accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristineM Higashigawa, M Ido, H Kuwabara, et al.Pageof 12